Table 1.
The control group (n = 24) | The titration group (n = 24) | |
---|---|---|
Age; yr | 38.1 (11.2) | 43.8 (9.5) |
Height; cm | 163 (4.6) | 161 (6.4) |
Weight; kg | 64.6 (11.9) | 61.6 (10.0) |
BMI; kg m−2 | 24.4 (4.0) | 23.7 (2.8) |
ASA, II, n (%) | 24 (100) | 22 (92) |
III, n (%) | 0 (0) | 2 (8) |
Hemoglobin, g dL−1 | 120 (18.8) | 116 (18.5) |
Hypertension, n (%) | 1 (4) | 4 (17) |
Diabetes, n (%) | 1 (4) | 0 (0) |
Anemia, n (%) | 1 (4) | 1 (4) |
Heart disease, n (%) | 0 (0) | 1 (4) |
Tidal volume; mL | 440 (35) | 430 (40) |
RR; breaths min−1 | 13 (1) | 13 (1) |
Intraoperative fluid input; mL | 1580 (680) | 1550 (480) |
Intraoperative bleeding; mL | 110 (250) | 120 (180) |
Intraoperative fluid output; mL | 480 (400) | 600 (340) |
Duration of operation; min | 139 (55) | 147 (65) |
Duration of ventilation; min | 180 (68) | 197 (56) |
Vasoactive drugs, n (%) | 5 (21) | 2 (8) |
Type of surgery, n (%) | ||
Oophorectomy | 11 (46) | 1 (4) |
Hysterectomy | 5 (21) | 14 (58) |
Adnexectomy | 2 (8) | 2 (8) |
Salpingoplasty | 2 (8) | 1 (4) |
Myomectomy | 2 (8) | 2 (8) |
Uterus repair | 2 (8) | 4 (17) |
Values are the mean (SD) or number (%). RR respiratory rate; VAS visual analog scale; PPCs postoperative pulmonary complications.